You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Indication

Cervarix is a vaccine for use from the age of 9 years for the prevention of premalignant ano-genital lesions (cervical, vulvar, vaginal and anal) and cervical and anal cancers causally related to certain oncogenic Human Papillomavirus (HPV) types. 1

The use of Cervarix should be in accordance with official recommendations.

Reference:

  1. Cervarix IPIVersion number: GDS024/ IPI019 / Date of issue: 02/Mar/15 2015 GSK group of companies

Cervarix is a registered trademark of GlaxoSmithKline group of companies.